Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.
about
A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivityCharacterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase componentsReduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteinsInnate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoformsSmall-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif.Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.Requirement of HIV-1 Vif C-terminus for Vif-CBF-β interaction and assembly of CUL5-containing E3 ligaseIdentification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteinsDeterminants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors.Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm VifIdentification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization.HIV-1, ubiquitin and ubiquitin-like proteins: the dialectic interactions of a virus with a sophisticated network of post-translational modifications.Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.Productive replication of Vif-chimeric HIV-1 in feline cells.Polyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif.APOBEC3 proteins and genomic stability: the high cost of a good defense
P2860
Q24656551-1D016096-F12B-43DA-AA86-7756C9C1ADFAQ28482052-CBCDAB17-CCD6-4DC5-AF51-AB600F27FF28Q31078477-77666964-CC62-46DC-9D54-D1ED46216B53Q33393637-9A1AD901-4AE8-4AE0-9A96-86498DCC7222Q34107265-C8CEF52C-0834-4A25-840B-1876F26DC7BAQ34179686-F55BB42D-D2E3-45DF-AA2E-CAFC04A5ED7BQ34416665-C828B46B-3DA6-4718-9B15-3D7D3686F6DCQ34539110-003A2AAF-7D99-430A-8CFC-00AA37F979D1Q34593794-C5D354B5-340A-4FF2-A52F-5A918418FCC0Q34695564-41CF6B4F-D7F2-4BC0-B077-2A7F8E4F1F2BQ35531709-8B55766A-344B-48E1-A61F-B6FBC32C025EQ37059673-CC45D4BB-16CA-4E6A-AD26-BB0E3CBF6C3FQ37099703-E6E7500B-6265-46F3-B4C5-00C11A82FF84Q37333725-85019BCD-31BE-4619-9297-54CB94572495Q37970436-B61C7F01-484E-494F-8DA6-1DCAAD4AE9D4Q38746224-F575F1EB-F892-454E-89D3-A3118E85EBBFQ39704599-8638439D-7F79-4718-B403-DCDCDCA4CA44Q39741166-BE1612F9-8CCB-4C9E-A7F5-556F52D5E3DEQ40848214-91337FED-8127-4DB7-82B7-D1C7F14E0213
P2860
Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Conserved and non-conserved fe ...... f APOBEC3 cytidine deaminases.
@en
Conserved and non-conserved fe ...... f APOBEC3 cytidine deaminases.
@nl
type
label
Conserved and non-conserved fe ...... f APOBEC3 cytidine deaminases.
@en
Conserved and non-conserved fe ...... f APOBEC3 cytidine deaminases.
@nl
prefLabel
Conserved and non-conserved fe ...... f APOBEC3 cytidine deaminases.
@en
Conserved and non-conserved fe ...... f APOBEC3 cytidine deaminases.
@nl
P2093
P2860
P1476
Conserved and non-conserved fe ...... f APOBEC3 cytidine deaminases.
@en
P2093
Chunjuan Tian
Michael Huang
Wenyan Zhang
Xianghui Yu
Xiao-Fang Yu
P2860
P304
P356
10.1111/J.1462-5822.2008.01157.X
P577
2008-04-16T00:00:00Z